Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches
Steven D Douglas, Steven D Douglas
No abstract availableKeywords: aprepitant; neurokinin 1 antagonist; pain; sickle cell disease; substance P.
Source: PubMed
Sponsorzy i współpracownicy
- GlaxoSmithKline
- Assiut University
- National Cancer Institute (NCI)
- Cairo University
- AstraZeneca
- Pfizer
- Assistance Publique - Hôpitaux de Paris
- Mayo Clinic
- M.D. Anderson Cancer Center
- Novartis Pharmaceuticals
- National Institute of Allergy and Infectious Diseases (NIAID)
- Massachusetts General Hospital
- National Taiwan University Hospital
- Boehringer Ingelheim
- Hoffmann-La Roche
- Merck Sharp & Dohme LLC
- Stanford University
- University of California, San Francisco
- Eli Lilly and Company
- Duke University
- Wyświetl pełną listę